Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination
- PMID: 18412782
- DOI: 10.1111/j.1447-0756.2008.00757.x
Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination
Abstract
Aim: To compare the effectiveness of vaginal misoprostol between dry tablet insertion and gel form for second trimester pregnancy termination.
Methods: A non-blinded block randomized controlled trial was conducted on 148 pregnant women with live fetuses in the second trimester undergoing pregnancy termination. They were randomly allocated to receive vaginal misoprostol (400 microg) either dry tablet insertion (n=72) or gel form (n=76). The same dose was then repeated every 3 h if adequate uterine contraction was not achieved until 48 h after the initiation of misoprostol. If abortion did not occur within this period, the treatment was considered a failure and other technique of termination was then given based on the decision of the attending physicians and the cervical status.
Results: The mean induction-abortion interval in group 1 (20.9+/-12.3 h) was not significantly different from that in group 2 (17.7+/-10.2 h). The mean total dose of misoprostol was also not significantly different between the two groups (group 1, 1556.9 microg; group 2, 1350.9 microg), but the adverse effects of misoprostol (chill and diarrhoea) were more common in the gel group.
Conclusion: Tablet insertion or gel form of vaginal misoprostol have similar effectiveness but the gel form was associated with more common adverse effects.
Similar articles
-
A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.BJOG. 2005 Sep;112(9):1297-301. doi: 10.1111/j.1471-0528.2005.00727.x. BJOG. 2005. PMID: 16101611 Clinical Trial.
-
Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.Acta Obstet Gynecol Scand. 2006;85(12):1458-62. doi: 10.1080/00016340601002282. Acta Obstet Gynecol Scand. 2006. PMID: 17260222 Clinical Trial.
-
A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.Trop Doct. 2010 Jul;40(3):144-8. doi: 10.1258/td.2010.100018. Trop Doct. 2010. PMID: 20555044 Clinical Trial.
-
Second-trimester induction of labor.Clin Obstet Gynecol. 2009 Jun;52(2):188-97. doi: 10.1097/GRF.0b013e3181a2b5d5. Clin Obstet Gynecol. 2009. PMID: 19407525 Review.
-
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8. Reprod Health Matters. 2008. PMID: 18772097 Review.
Cited by
-
Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.Sci Rep. 2017 May 10;7(1):1664. doi: 10.1038/s41598-017-01892-0. Sci Rep. 2017. PMID: 28490770 Free PMC article.
-
Misoprostol versus High Dose Oxytocin and Laminaria in Termination of Pregnancy in Second Trimester Pregnancies.Electron Physician. 2013 Nov 1;5(4):713-8. doi: 10.14661/2013.713-718. eCollection 2013 Oct-Dec. Electron Physician. 2013. PMID: 26120407 Free PMC article.
-
Medical methods for mid-trimester termination of pregnancy.Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD005216. doi: 10.1002/14651858.CD005216.pub2. Cochrane Database Syst Rev. 2011. PMID: 21249669 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical